Found: 10
Select item for more details and to access through your institution.
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL).
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 381, doi. 10.1007/s11864-021-00932-2
- By:
- Publication type:
- Article
Advances in cellular and humoral immunotherapy – implications for the treatment of poor risk childhood, adolescent, and young adult B‐cell non‐Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 6, p. 1055, doi. 10.1111/bjh.15753
- By:
- Publication type:
- Article
Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 4, p. 597, doi. 10.1111/bjh.14078
- By:
- Publication type:
- Article
Adoptive cellular therapy after hematopoietic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 910, doi. 10.1002/ajh.27204
- By:
- Publication type:
- Article
Regulation of histone modification and cryptic transcription by the Bur1 and Paf1 complexes.
- Published in:
- EMBO Journal, 2007, v. 26, n. 22, p. 4646, doi. 10.1038/sj.emboj.7601887
- By:
- Publication type:
- Article
Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1211505
- By:
- Publication type:
- Article
Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00051
- By:
- Publication type:
- Article
Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases and Serum Antibody Changes Post-Omicron Variant Infection.
- Published in:
- Rheumatology & Therapy, 2024, v. 11, n. 1, p. 191, doi. 10.1007/s40744-023-00630-5
- By:
- Publication type:
- Article
Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 6, p. 788, doi. 10.1093/infdis/jiac500
- By:
- Publication type:
- Article
Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56 Dim NK cells.
- Published in:
- Innate Immunity, 2019, v. 25, n. 5, p. 294, doi. 10.1177/1753425919846584
- By:
- Publication type:
- Article